Why the study?
Does a Vero cell-derived whole-virus H5N1 vaccine induce neuraminidase-inhibiting antibodies in humans?
Population
Humans receiving H5N1 vaccination
Design
Other
Authors
Loading...
May support single-dose H5N1 priming for NAi; leaves open optimal regimens and durability for pandemic use.
Does a Vero cell-derived whole-virus H5N1 vaccine induce neuraminidase-inhibiting antibodies in humans?
A Vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies in humans, which may be important for pandemic preparedness.
Fritz et al. (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: